Re-Registration

SESSION 1: Liver Cirrhosis – Variceal Bleeding Case-Based Study
• Management of Portal Hypertensive Gastropathy
• Management of Acute Variceal Bleeding

Panelist: Juferdy Kurniawan & Cosmas Rinaldi A. Lesmana

LECTURE 1: Long-Term Albumin Use in Cirrhosis: A Strategy to Enhance
Patient Survival

Speaker: Cosmas Rinaldi A. Lesmana

SESSION 2: Case-Based Insights into Ascites Management in Liver
Cirrhosis
• Managing Hyponatremia in Cirrhotic Ascites: Challenges and Clinical
Strategies
• Optimizing Paracentesis: Evaluating the Role of Colloids in Moderate Fluid
Removal

Panelist: Irsan Hasan & Imelda Maria Loho

SESSION 3: Liver Failure Case-Based Study
• Recent Management of ALF (Acute Liver Failure)
• Recent Management of ACLF (Acute-on-Chronic Liver Failure)

Panelist: Kemal Fariz Kalista & Rino Alvani Gani

LECTURE 2: Laxatives in Cirrhosis: More Than Just Bowel Management?

Speaker: Andri Sanityoso Sulaiman

SESSION 4: MAFLD Case-Based Study
• MAFLD diagnosis and risk assessment
• Continuity care and treatment of MAFLD

Panelist: Chyntia Olivia M. Jasirwan & Saut Horas H. Nababan

Registration

SESSION 5: HCC Case-Based Study
• Role of PIVKA-II in the Diagnosis and Surveillance of Hepatocellular
Carcinoma (HCC): Emphasis on Non-B Non-C HCC
• Treatment Decision-Making for Unresectable Hepatocellular Carcinoma:
Systemic Therapy or Chemoembolization

Panelist: Lianda Siregar & Imelda Maria Loho

LECTURE 3: Immunotherapy for treatment of intermediate and advance HCC

Speaker: Irsan Hasan

SESSION 6: Liver & Systemic Disease Case-Based Study
• Cardiac-Related Liver Dysfunction: Exploring the Heart-Liver Connection
• Hepatic Dysfunction in Sepsis: Diagnosis and Management Strategies

Panelist: Saut Horas H. Nababan & Pitt Akbar

SESSION 8: Liver Transplant Case-Based Study
• When is It Time? Indications for Liver Transplantation in Cirrhosis – MELD
and Beyond
•Indications for LT in HCC Patients

Panelist: Kemal Fariz Kalista & Rino Alvani Gani

LECTURE 4: Hepatitis B WHO Guideline

Speaker: Juferdy Kurniawan

SESSION 7: Hepatitis Viral Case Based Study
• Assessing Hepatocellular Carcinoma Risk in Viral Hepatitis Patients:
Strategies and Tools
• Strategies to Prevent Hepatitis B Reactivation in Patients Receiving
Immunosuppressive Treatment

Panelist: Andri Sanityoso Sulaiman & Pitt Akbar